|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0450 CAD | +12.50% |
|
+50.00% | -30.77% |
| Market Cap | 3.09M 2.18M 1.92M 1.78M 1.64M 209M 3.16M 21.22M 8.3M 103M 8.21M 8.03M 355M | P/E 2024 |
-9.02x | P/E 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 3.27M 2.31M 2.03M 1.88M 1.73M 221M 3.34M 22.41M 8.77M 109M 8.67M 8.48M 375M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
84.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +12.50% | ||
| 1 week | +50.00% | ||
| 1 month | +28.57% | ||
| 3 months | +28.57% | ||
| 6 months | -43.75% | ||
| Current year | -30.77% |
| 1 week | 0.03 | 0.04 | |
| 1 month | 0.03 | 0.04 | |
| Current year | 0.03 | 0.1 | |
| 1 year | 0.02 | 0.14 | |
| 3 years | 0.02 | 0.2 | |
| 5 years | 0.02 | 0.95 | |
| 10 years | 0.02 | 4.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roberto Fia
CEO | Chief Executive Officer | 55 | - |
Sung Min Myung
DFI | Director of Finance/CFO | 40 | 2019-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Fia
BRD | Director/Board Member | 55 | 2014-11-09 |
Andrew Peterson
CHM | Chairman | 78 | - |
Steve Naraine
BRD | Director/Board Member | - | 2023-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-14 | Sell | Chief Executive Officer | 2,000,000 | 4.3702% | ||
| 05-14 | Sell | Chief Executive Officer | 2,000,000 | 4.3702% | ||
| 03-03 | Tax | Chief Executive Officer | 187,500 | 0.4097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +12.50% | +50.00% | +125.00% | -55.00% | 2.19M | ||
| +1.90% | +1.82% | -11.27% | -6.90% | 12.85B | ||
| +3.59% | +5.01% | -31.29% | -52.81% | 4.79B | ||
| +4.15% | +3.48% | -3.60% | -5.91% | 4.4B | ||
| +6.19% | +5.44% | +10.39% | -32.89% | 3.82B | ||
| +3.72% | -3.85% | +15.82% | -4.31% | 3.68B | ||
| +2.71% | +9.52% | -6.14% | -8.78% | 3.26B | ||
| +2.13% | +2.71% | -9.27% | +6.52% | 3.1B | ||
| +1.03% | +2.29% | -7.29% | -21.36% | 2.41B | ||
| +4.33% | +9.31% | -1.05% | +52.08% | 1.8B | ||
| Average | +4.22% | +6.86% | +8.13% | -12.94% | 4.01B | |
| Weighted average by Cap. | +3.07% | +3.55% | -6.99% | -11.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -388K -274K -241K -223K -205K -26.22M -397K -2.66M -1.04M -12.89M -1.03M -1.01M -44.54M | -1.06M -752K -661K -613K -564K -71.92M -1.09M -7.3M -2.86M -35.36M -2.82M -2.76M -122M |
| Net Debt | 68.01K 48.02K 42.22K 39.15K 36K 4.6M 69.49K 467K 183K 2.26M 180K 177K 7.81M | 174K 123K 108K 100K 92.08K 11.75M 178K 1.19M 467K 5.78M 462K 451K 19.96M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-13 | $0.0450 | +12.50% | 26,000 |
| 26-07-10 | $0.0400 | 0.00% | 56,000 |
| 26-07-09 | $0.0400 | +14.29% | 14,000 |
| 26-07-08 | $0.0350 | +16.67% | 6,000 |
| 26-07-07 | $0.0300 | -33.33% | 124,000 |
- Stock Market
- Stocks
- CVGR Stock
Select your edition
All financial news and data tailored to specific country editions
















